Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Dec 26 2021

[Blocked from Release] 01082018

  • Snapshot
    • A
  • Introduction
    • Clinical definition
      • arthritis affecting a single joint
        • there are various causes
  • Epidemiology
    • Risk factors
      • prosthetic joint
        • e.g., S. epidermidis
  • Etiology
    • Trauma
    • Crystal-induced arthropathy (e.g., gout)
    • Infection
      • gonococcal
      • nongonoccal
        • S. aureus (most common)
        • S. pneumoniae
        • gram-negative bacteria
    • Seronegative spondyloarthritis such as
      • reactive arthritis
      • psoriatic arthritis
      • inflammatory bowel disease-associated arthritis
    • Osteoarthritis
    • Malignancy
  • Presentation
    • Symptoms
      • pain that
        • is worsened by movement of the joint
        • decreases the range of motion of the joint
          • not the case in deep-seated joints (e.g., shoulder and hip)
        • is accompanied by swelling or erythema
          • not the case in deep-seated joints (e.g., shoulder and hip)
    • Physical exam
      • A
  • Imaging
    • A
  • Studies
    • Arthrocentesis
    • Synovial fluid analysis
  • Differential
    • A
  • Treatment
    • Medical
    • Operative
  • Evaluation
    • Assume infected until proven otherwise.
    • Radiograph
      • shows joint space widening
    • Arthrocentesis findings
    • DiseaseFindings
      Gout
      • Negatively birefringent needle-shaped crystals
      • WBC < 50,000 mm3
      Pseudogout
      • Positively birefringent rhomboid crystals
      Infection
      • WBC > 50,000 mm3
      • > 75% of neutrophils
      • Low glucose
      Arthritis
      • WBC = 20,000 to 50,000 mm3
  • Treatment
    • Antibiotics
      • vancomycin + 3rd generation cephalosporin
      • If gram positive and patient not at risk (not IVDU or immunocompetent)
        • IV vancomycin
      • If gram negative and patient not at risk (not IVDU or immunocompetent)
        • 3rd generation cephalosporin (e.g. IV ceftriaxone)
      • consider adding pseudomonas coverage for immunocompromised or at risk patients
  • Complications
    • A
  • Prognosis
    • dependent on the underlying cause of monoarthritis
Card
1 of 0
Private Note